- Home
- COCP vs BGI Comparison
COCP vs BGI Comparison
Compare COCP & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCP
- BGI
- Stock Information
- Founded
- COCP 2006
- BGI 1879
- Country
- COCP United States
- BGI Canada
- Employees
- COCP N/A
- BGI N/A
- Industry
- COCP Biotechnology: Pharmaceutical Preparations
- BGI
- Sector
- COCP Health Care
- BGI
- Exchange
- COCP Nasdaq
- BGI Nasdaq
- Market Cap
- COCP 15.4M
- BGI 15.9M
- IPO Year
- COCP N/A
- BGI 2005
- Fundamental
- Price
- COCP $1.37
- BGI $1.31
- Analyst Decision
- COCP Strong Buy
- BGI
- Analyst Count
- COCP 1
- BGI 0
- Target Price
- COCP $6.00
- BGI N/A
- AVG Volume (30 Days)
- COCP 4.3M
- BGI 187.2K
- Earning Date
- COCP 11-12-2025
- BGI 07-25-2025
- Dividend Yield
- COCP N/A
- BGI N/A
- EPS Growth
- COCP N/A
- BGI N/A
- EPS
- COCP N/A
- BGI N/A
- Revenue
- COCP N/A
- BGI $124,446,731.00
- Revenue This Year
- COCP N/A
- BGI N/A
- Revenue Next Year
- COCP N/A
- BGI N/A
- P/E Ratio
- COCP N/A
- BGI N/A
- Revenue Growth
- COCP N/A
- BGI N/A
- 52 Week Low
- COCP $1.12
- BGI $0.56
- 52 Week High
- COCP $3.26
- BGI $2.40
- Technical
- Relative Strength Index (RSI)
- COCP 38.00
- BGI 84.24
- Support Level
- COCP $1.31
- BGI $0.64
- Resistance Level
- COCP $2.67
- BGI $0.97
- Average True Range (ATR)
- COCP 0.16
- BGI 0.12
- MACD
- COCP -0.01
- BGI 0.04
- Stochastic Oscillator
- COCP 4.42
- BGI 71.51
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.